GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review

Date: February 22, 2017
Pages: 43
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G8DC1FEF4EFEN
Leaflet:

Download PDF Leaflet

GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review
GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the treatment of spasticity due to multiple sclerosis. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. GW Pharmaceuticals is also developing other products that are focused at treating Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis, infantile spasms, epilepsy, glioma, schizophrenia, autism among others. The company along with its subsidiaries operates in the US, England and Wales. GW Pharmaceuticals is headquartered in Salisbury, Wiltshire, the UK.

GW Pharmaceuticals Plc Key Recent Developments

Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress
Dec 05, 2016: GW Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress
Aug 09, 2016: GW Pharmaceuticals Reports Third Quarter 2016 Financial Results and Operational Progress
May 05, 2016: GW Pharmaceuticals Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
Feb 10, 2016: GW Pharmaceuticals Reports First Quarter 2016 Financial Results and Operational Progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    GW Pharmaceuticals Plc - Key Facts
    GW Pharmaceuticals Plc - Key Employees
    GW Pharmaceuticals Plc - Key Employee Biographies
    GW Pharmaceuticals Plc - Major Products and Services
    GW Pharmaceuticals Plc - Pharmaceutical Pipeline Products Data
    GW Pharmaceuticals Plc, Pipeline Products by Therapy Area
    GW Pharmaceuticals Plc, Pipeline Products by Development Phase
    GW Pharmaceuticals Plc - History
    GW Pharmaceuticals Plc - Company Statement
    GW Pharmaceuticals Plc - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    GW Pharmaceuticals Plc - Business Description
    GW Pharmaceuticals Plc - Corporate Strategy
    GW Pharmaceuticals Plc - SWOT Analysis
    SWOT Analysis - Overview
    GW Pharmaceuticals Plc - Strengths
    GW Pharmaceuticals Plc - Weaknesses
    GW Pharmaceuticals Plc - Opportunities
    GW Pharmaceuticals Plc - Threats
    GW Pharmaceuticals Plc - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
    GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
    GW Pharmaceuticals Plc, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress
    Dec 05, 2016: GW Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress
    Aug 09, 2016: GW Pharmaceuticals Reports Third Quarter 2016 Financial Results and Operational Progress
    May 05, 2016: GW Pharmaceuticals Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
    Feb 10, 2016: GW Pharmaceuticals Reports First Quarter 2016 Financial Results and Operational Progress
    Jan 05, 2016: Cannabis-based drug reduces seizures in children with treatment-resistant epilepsy

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    GW Pharmaceuticals Plc, Key Facts
    GW Pharmaceuticals Plc, Key Employees
    GW Pharmaceuticals Plc, Key Employee Biographies
    GW Pharmaceuticals Plc, Major Products and Services
    GW Pharmaceuticals Plc, Number of Pipeline Products by Therapy Area
    GW Pharmaceuticals Plc, Number of Pipeline Products by Development Stage
    GW Pharmaceuticals Plc, History
    GW Pharmaceuticals Plc, Other Locations
    GW Pharmaceuticals Plc, Subsidiaries
    GW Pharmaceuticals Plc, Key Competitors
    GW Pharmaceuticals Plc, Ratios based on current share price
    GW Pharmaceuticals Plc, Annual Ratios
    GW Pharmaceuticals Plc (Cont...1), Annual Ratios
    GW Pharmaceuticals Plc, Interim Ratios
    GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
    GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
    GW Pharmaceuticals Plc, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    GW Pharmaceuticals Plc, Pipeline Products by Therapy Area
    GW Pharmaceuticals Plc, Pipeline Products by Development Phase
    GW Pharmaceuticals Plc, Performance Chart (2012 - 2016)
    GW Pharmaceuticals Plc, Ratio Charts
    GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
    GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
    Skip to top


    Ask Your Question

    GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: